Home
|
Help
|
Contact
Sign in
WPRIM Management System>
DCMS
>
Journal of Breast Cancer
>
2018
>
21
>
3
Volume:
21
Issue:
3
1. Deficiency of Follistatin-Like Protein 1 Accelerates the Growth of Breast Cancer Cells at Lung Metastatic Sites.
Page:267—276
2. Hypoxia-Inducible Factor 1α Regulates the Transforming Growth Factor β1/SMAD Family Member 3 Pathway to Promote Breast Cancer Progression.
Page:259—266
3. Hsa-miRNA-143-3p Reverses Multidrug Resistance of Triple-Negative Breast Cancer by Inhibiting the Expression of Its Target Protein Cytokine-Induced Apoptosis Inhibitor 1 In Vivo.
Page:251—258
4. Patterns of Practice in Radiotherapy for Breast Cancer in Korea.
Page:244—250
5. The Epigenetics of Triple-Negative and Basal-Like Breast Cancer: Current Knowledge.
Page:233—243
6. Extraocular Muscles Involvement as the Initial Presentation in Metastatic Breast Cancer.
Page:339—342
7. Gasless Robot-Assisted Nipple-Sparing Mastectomy: A Case Report.
Page:334—338
8. The Novel Pathogenic Mutation c.849dupT in BRCA2 Contributes to the Nonsense-Mediated mRNA Decay of BRCA2 in Familial Breast Cancer.
Page:330—333
9. Comparison of Oncoplastic Breast-Conserving Surgery and Breast-Conserving Surgery Alone: A Meta-Analysis.
Page:321—329
10. Evaluating the Prediction of Breast Cancer Survival Using Lymph Node Ratio.
Page:315—320
11. Comparative Study between Sentinel Lymph Node Biopsy and Axillary Dissection in Patients with One or Two Lymph Node Metastases.
Page:306—314
12. Expression of DNA Damage Response Proteins and Associations with Clinicopathologic Characteristics in Chinese Familial Breast Cancer Patients with BRCA1/2 Mutations.
Page:297—305
13. High RNA-binding Motif Protein 3 Expression Is Associated with Improved Clinical Outcomes in Invasive Breast Cancer.
Page:288—296
14. Long Noncoding RNA Signature and Disease Outcome in Estrogen Receptor-Positive Breast Cancer Patients Treated with Tamoxifen.
Page:277—287